866-997-4948(US-Canada Toll Free)

United States Nonsteroidal Antiinflammatory Drugs Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 102 Pages

In this report, the United States Nonsteroidal Antiinflammatory Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.



Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Nonsteroidal Antiinflammatory Drugs in these regions, from 2012 to 2022 (forecast).



United States Nonsteroidal Antiinflammatory Drugs market competition by top manufacturers/players, with Nonsteroidal Antiinflammatory Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Sanofi S.A.

Novartis AG

GlaxoSmithKline PLC

Pfizer

DOMESCO

...



On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Oral

Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nonsteroidal Antiinflammatory Drugs for each application, including

Osteoarthritis

Muscle Aches

Backaches

Dental Pain

Others



If you have any special requirements, please let us know and we will offer you the report as you want.



Table of Contents

United States Nonsteroidal Antiinflammatory Drugs Market Report 2017
1 Nonsteroidal Antiinflammatory Drugs Overview
1.1 Product Overview and Scope of Nonsteroidal Antiinflammatory Drugs
1.2 Classification of Nonsteroidal Antiinflammatory Drugs by Product Category
1.2.1 United States Nonsteroidal Antiinflammatory Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Nonsteroidal Antiinflammatory Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Oral
1.2.4 Injection
1.3 United States Nonsteroidal Antiinflammatory Drugs Market by Application/End Users
1.3.1 United States Nonsteroidal Antiinflammatory Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Osteoarthritis
1.3.3 Muscle Aches
1.3.4 Backaches
1.3.5 Dental Pain
1.3.6 Others
1.4 United States Nonsteroidal Antiinflammatory Drugs Market by Region
1.4.1 United States Nonsteroidal Antiinflammatory Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
1.4.5 New England Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
1.4.6 The South Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nonsteroidal Antiinflammatory Drugs (2012-2022)
1.5.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2022)

2 United States Nonsteroidal Antiinflammatory Drugs Market Competition by Players/Suppliers
2.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nonsteroidal Antiinflammatory Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Nonsteroidal Antiinflammatory Drugs Market Competitive Situation and Trends
2.4.1 United States Nonsteroidal Antiinflammatory Drugs Market Concentration Rate
2.4.2 United States Nonsteroidal Antiinflammatory Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nonsteroidal Antiinflammatory Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nonsteroidal Antiinflammatory Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Nonsteroidal Antiinflammatory Drugs Price by Region (2012-2017)

4 United States Nonsteroidal Antiinflammatory Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Nonsteroidal Antiinflammatory Drugs Price by Type (2012-2017)
4.4 United States Nonsteroidal Antiinflammatory Drugs Sales Growth Rate by Type (2012-2017)

5 United States Nonsteroidal Antiinflammatory Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Nonsteroidal Antiinflammatory Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Nonsteroidal Antiinflammatory Drugs Players/Suppliers Profiles and Sales Data
6.1 Sanofi S.A.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis AG
6.2.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline PLC
6.3.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 DOMESCO
6.5.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...

7 Nonsteroidal Antiinflammatory Drugs Manufacturing Cost Analysis
7.1 Nonsteroidal Antiinflammatory Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nonsteroidal Antiinflammatory Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Nonsteroidal Antiinflammatory Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Nonsteroidal Antiinflammatory Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nonsteroidal Antiinflammatory Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Nonsteroidal Antiinflammatory Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Nonsteroidal Antiinflammatory Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Nonsteroidal Antiinflammatory Drugs
Figure United States Nonsteroidal Antiinflammatory Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Injection Product Picture
Figure United States Nonsteroidal Antiinflammatory Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Nonsteroidal Antiinflammatory Drugs by Application in 2016
Figure Osteoarthritis Examples
Table Key Downstream Customer in Osteoarthritis
Figure Muscle Aches Examples
Table Key Downstream Customer in Muscle Aches
Figure Backaches Examples
Table Key Downstream Customer in Backaches
Figure Dental Pain Examples
Table Key Downstream Customer in Dental Pain
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Nonsteroidal Antiinflammatory Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nonsteroidal Antiinflammatory Drugs Sales Share by Players/Suppliers
Figure 2017 United States Nonsteroidal Antiinflammatory Drugs Sales Share by Players/Suppliers
Figure United States Nonsteroidal Antiinflammatory Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nonsteroidal Antiinflammatory Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Nonsteroidal Antiinflammatory Drugs Revenue Share by Players/Suppliers
Table United States Market Nonsteroidal Antiinflammatory Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Nonsteroidal Antiinflammatory Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Nonsteroidal Antiinflammatory Drugs Market Share of Top 3 Players/Suppliers
Figure United States Nonsteroidal Antiinflammatory Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nonsteroidal Antiinflammatory Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nonsteroidal Antiinflammatory Drugs Product Category
Table United States Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Sales Share by Region (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Share by Region (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region in 2016
Table United States Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Revenue Share by Region (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region in 2016
Table United States Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2016
Table United States Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonsteroidal Antiinflammatory Drugs by Type (2012-2017)
Figure Revenue Market Share of Nonsteroidal Antiinflammatory Drugs by Type in 2016
Table United States Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Growth Rate by Type (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2016
Table United States Nonsteroidal Antiinflammatory Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Growth Rate by Application (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2012-2017)
Figure Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Nonsteroidal Antiinflammatory Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Nonsteroidal Antiinflammatory Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline PLC Basic Information List
Table GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Nonsteroidal Antiinflammatory Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Nonsteroidal Antiinflammatory Drugs Revenue Market Share in United States (2012-2017)
Table DOMESCO Basic Information List
Table DOMESCO Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure DOMESCO Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2012-2017)
Figure DOMESCO Nonsteroidal Antiinflammatory Drugs Sales Market Share in United States (2012-2017)
Figure DOMESCO Nonsteroidal Antiinflammatory Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonsteroidal Antiinflammatory Drugs
Figure Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
Figure Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
Table Raw Materials Sources of Nonsteroidal Antiinflammatory Drugs Major Players/Suppliers in 2016
Table Major Buyers of Nonsteroidal Antiinflammatory Drugs
Table Distributors/Traders List
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Nonsteroidal Antiinflammatory Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Nonsteroidal Antiinflammatory Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nonsteroidal Antiinflammatory Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *